286 On Other Exchanges
Symbol
Exchange
286 is not on other exchanges.

common splendor internationa (286) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for COMMON SPLENDOR INTERNATIONA (286)

Related News

No related news articles were found.

common splendor internationa (286) Related Businessweek News

No Related Businessweek News Found

common splendor internationa (286) Details

Common Splendor International Health Industry Group Limited, an investment holding company, provides precision life healthcare services in the People’s Republic of China and Hong Kong. The company focuses on operating life club and health preserving base chain that offers a range of precision life healthcare services, such as medical anti-aging, suboptimal health interference and private doctor services, and health maintenance services to the elite groups. It is also involved in the healthcare investment management, natural health food, advantage growth for children, bio-medical technology, and investment and finance businesses. The company was formerly known as G-Prop (Holdings) Limited and changed its name to Common Splendor International Health Industry Group Limited in December 2013. The company was incorporated in 1990 and is based in Tsim Sha Tsui, Hong Kong. Common Splendor International Health Industry Group Limited is a subsidiary of Champion Dynasty Limited.

279 Employees
Last Reported Date: 04/29/16
Founded in 1990

common splendor internationa (286) Top Compensated Officers

Chief Executive Officer and Executive Directo...
Total Annual Compensation: $38.0K
Chairman
Total Annual Compensation: $650.0K
Deputy Chairman
Total Annual Compensation: $1.6M
Compensation as of Fiscal Year 2015.

common splendor internationa (286) Key Developments

Common Splendor International Health Industry Group Limited, Annual General Meeting, May 31, 2016

Common Splendor International Health Industry Group Limited, Annual General Meeting, May 31, 2016, at 16:00 China Standard Time. Location: Room 2709-10, 27th Floor, North Tower Concordia Plaza, 1 Science Museum Road Tsim Sha Tsui Kowloon Hong Kong Agenda: To receive and consider the audited consolidated financial statements, Directors’ report and auditor’s report for the year ended 31 December 2015; to consider re-election of directors and to authorise the Directors to fix the remuneration of the Directors; to re-appoint HLB Hodgson Impey Cheng Limited as auditor and to authorise the Directors to fix the remuneration of the auditor; to give a general mandate to the Directors to purchase shares of the Company; to give a general mandate to the Directors to issue, allot and deal with shares of the Company; to consider conditional upon the passing of resolutions nos. 4 and 5, to extend the general mandate given to the Directors to issue, allot and deal with shares not exceeding the aggregate number of shares repurchased pursuant to the general mandate granted under resolution no. 4; and to refresh the Option Scheme Mandate Limit.

Common Splendor International Health Industry Group Limited Reports Audited Consolidated Earnings Results for the Year Ended December 31, 2015

Common Splendor International Health Industry Group Limited reported audited consolidated earnings results for the year ended December 31, 2015. For the year, the company reported revenue was HKD 530,290,000 against HKD 359,818,000 a year ago. The increase was mainly attributable to the increase in the sales of medical chemical materials from approximately HKD 50,049,000 in 2014 to approximately HKD 273,467,000 in 2015. Profit before tax was HKD 49,052,000 against HKD 32,957,000 a year ago. Profit for the year from continuing operations was HKD 42,106,000 against HKD 25,330,000 a year ago. Profit attributable to owners of the company was HKD 34,009,000 or 1.36 cents per basic and diluted share against HKD 27,505,000 or 0.79 cents per diluted share a year ago. Net cash generated from operating activities was HKD 116,885,000 against net cash used in operating activities of HKD 88,594,000 a year ago. Purchase of property, plant and equipment was HKD 5,357,000 against HKD 13,297,000 a year ago. Net debt was HKD 15,734,000.

Common Splendor International Health Industry Group Limited Reports Consolidated Earnings Results for the Year Ended December 31, 2015

Common Splendor International Health Industry Group Limited reported consolidated earnings results for the year ended December 31, 2015. For the year, the company reported revenue was HKD 530,290,000 against HKD 359,818,000 a year ago. The increase was mainly attributable to the increase in the sales of medical chemical materials from approximately HKD 50,049,000 in 2014 to approximately HKD 273,467,000 in 2015. Profit before tax was HKD 49,052,000 against HKD 32,957,000 a year ago. Profit for the year from continuing operations was HKD 42,106,000 or 1.05 cents per diluted share against HKD 25,330,000 or 0.79 cents per diluted share a year ago. Profit attributable to owners of the company was HKD 34,009,000 or 1.05 cents per diluted share against HKD 27,505,000 or 0.79 cents per diluted share a year ago.

 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

286 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 286.
View Industry Companies
 

Industry Analysis

286

Industry Average

Valuation 286 Industry Range
Price/Earnings 50.1x
Price/Sales 3.3x
Price/Book 3.5x
Price/Cash Flow 51.9x
TEV/Sales 3.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact COMMON SPLENDOR INTERNATIONA, please visit www.cs-ih.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.